* IRIDEX Corp IRIX.OQ reported a quarterly adjusted loss
of 15
cents per share for the quarter ended in December. The mean
expectation of two analysts for the quarter was for a loss of 11
cents per share.
* Revenue rose 24% to $15.25 million from a year ago;
analysts
expected $14.69 million.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* IRIDEX Corp shares had fallen by 28.3% this quarter.
* Wall Street's median 12-month price target for IRIDEX Corp
is
$9.75
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated March 11 at 12:26 a.m. All
figures in US dollars unless otherwise stated